MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Experience of pallidal deep brain stimulation (DBS) in dystonia at a tertiary care centre in India

    D. Srinivas, R. Yadav, K. Jhunjhunwala, P. Pal (Bangalore, India)

    Objective: The therapeutic role of Deep Brain Stimulation (DBS) has expanded for severe primary and secondary dystonias. Till date, only a few centres in India…
  • 2016 International Congress

    Predictors of onabotulinumtoxinA treatment response in patients with cervical dystonia

    J. Jankovic, S. Marc, A. Aubrey (Houston, TX, USA)

    Objective: Data from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy), an observational, multicenter, prospective clinical registry, were analyzed to try to…
  • 2016 International Congress

    Clinical effects of pallidal stimulation in dystonia are quantitatively related to intracortical inhibition

    A. Fecíková, V. Cejka, V. Capek, F. Ruzicka, V. Bocek, D. Štastná, I. Štetkárová, D. Urgošík, R. Jech (Praha, Czech Republic)

    Objective: To distinguish between patients with dystonia according to the clinical outcome of pallidal stimulation (GPi DBS) using intracortical inhibition of the motor cortex assessed…
  • 2016 International Congress

    Distinguishing pseudo-dystonia from dystonia: A case series

    L.E. Katus, S.J. Frucht (New York, NY, USA)

    Objective: To characterize various presentations of pseudo-dystonia and features that distinguish it from dystonia based on review of 12 video cases and the published literature.…
  • 2016 International Congress

    Improvement of levodopa induced foot dystonia with 60 Hz frequency subthalamic- deep brain stimulation

    J.P. Battista, R.A. Ramdhani (New York, NY, USA)

    Objective: To present a case of levodopa induced foot dystonia that improved with 60Hz frequency subthalamic- deep brain stimulation. Background: Deep Brain Stimulation is an…
  • 2016 International Congress

    Clinical outcomes of pallidal and subthalamic nucleus deep brain stimulation in isolated cranial and cranio-cervical dystonia

    N.S. Luthra, K.A. Dodenhoff, M. San Luciano, M.M. Volz, S.L. Heath, P.A. Starr, J.L. Ostrem (San Francisco, CA, USA)

    Objective: To evaluate clinical outcomes of deep brain stimulation (DBS) of globus pallidus internus (GPi) or subthalamic nucleus (STN) for isolated cranial or cranio-cervical dystonia.…
  • 2016 International Congress

    Botulinum neurotoxins type A versus B for cervical dystonia in adults – 2016 Cochrane movement disorders group systematic review update

    M. Castelão, G.S. Duarte, F.B. Rodrigues, R.E. Marques, J.J. Ferreira, P. Moore, J. Costa (Lisboa, Portugal)

    Objective: To update a Cochrane review comparing botulinum neurotoxin type A (BtA) to type B (BtB) in adults with cervical dystonia (CD). Background: This is…
  • 2016 International Congress

    Clinical course and treatment of 6 children with GNAO1 mutations causing a severe, life-threatening chorea

    A. Robichaux-Viehoever, A. Ananth, Y.M. Kim, A. Hanson-Kahn, R. Cox, G. Enns, J. Strober, M. Willing, B. Schlaggar, J. Bernstein, Y. Wu (San Francisco, CA, USA)

    Objective: We describe the clinical course of 6 patients with de novo GNAO1 mutations with severe chorea, developmental delay and hypotonia, but the absence of…
  • 2016 International Congress

    Risk factors associated with postural changes in Parkinson’s disease

    A. Khlebtovsky, O. Keret, Y. Rodity, G. Tsvetov, I. Slutzcki-Shraga, F. Benninger, R. Djaldetti (Petach Tikva, Israel)

    Objective: To quantitatively assess posture in a large cohort of patients with PD in association with demographic features, laboratory data and life style and to…
  • 2016 International Congress

    Comparing quality of PD care in a comprehensive clinic to specialist care

    S.A. Factor, L.P. Prizer, F.C. Goldstein, L.M. Trotti, A. Hermida, C. Vaughan (Atlanta, GA, USA)

    Objective: To compare the quality of care according to the AAN quality indicators for PD through a comprehensive PD care model vs. an academic movement…
  • « Previous Page
  • 1
  • …
  • 151
  • 152
  • 153
  • 154
  • 155
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley